117 related articles for article (PubMed ID: 25727340)
1. Feeding cancer's sweet tooth: specialized tumour vasculature shuttles glucose in pancreatic ductal adenocarcinoma.
Dudley AC; Bautch VL
J Pathol; 2015 Jun; 236(2):133-5. PubMed ID: 25727340
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma.
Hexige S; Ardito-Abraham CM; Wu Y; Wei Y; Fang Y; Han X; Li J; Zhou P; Yi Q; Maitra A; Liu JO; Tuveson DA; Lou W; Yu L
J Pathol; 2015 Jun; 236(2):142-154. PubMed ID: 25561062
[TBL] [Abstract][Full Text] [Related]
3. Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma.
Hoem D; Straume O; Immervoll H; Akslen LA; Molven A
APMIS; 2013 Nov; 121(11):1037-46. PubMed ID: 23489215
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma.
Dallas NA; Gray MJ; Xia L; Fan F; van Buren G; Gaur P; Samuel S; Lim SJ; Arumugam T; Ramachandran V; Wang H; Ellis LM
Clin Cancer Res; 2008 Dec; 14(24):8052-60. PubMed ID: 19088020
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
[TBL] [Abstract][Full Text] [Related]
6. Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma.
Sabbaghian MS; Rothberger G; Alongi AP; Gagner JP; Goldberg JD; Rolnitzky L; Chiriboga L; Hajdu CH; Zagzag D; Basch R; Shamamian P
Anticancer Res; 2010 Jul; 30(7):2911-7. PubMed ID: 20683032
[TBL] [Abstract][Full Text] [Related]
7. Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcinoma.
Kotopoulis S; Stigen E; Popa M; Safont MM; Healey A; Kvåle S; Sontum P; Gjertsen BT; Gilja OH; McCormack E
J Control Release; 2017 Jan; 245():70-80. PubMed ID: 27871988
[TBL] [Abstract][Full Text] [Related]
8. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P
Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886
[TBL] [Abstract][Full Text] [Related]
9. Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.
Craven KE; Gore J; Korc M
Cancer Lett; 2016 Oct; 381(1):201-10. PubMed ID: 26723874
[TBL] [Abstract][Full Text] [Related]
10. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.
Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
Eur J Surg Oncol; 2014 Oct; 40(10):1331-7. PubMed ID: 24480377
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer cells expressing hypoxia-inducible factor-1α tend to be adjacent to intratumoral blood vessels.
Cheng BQ; Segersvärd R; Permert J; Wang F
Eur Surg Res; 2010; 45(3-4):134-7. PubMed ID: 20924188
[TBL] [Abstract][Full Text] [Related]
12. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.
Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533
[TBL] [Abstract][Full Text] [Related]
13. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
14. Combining conventional and stroma-derived tumour markers in pancreatic ductal adenocarcinoma.
Franklin O; Öhlund D; Lundin C; Öman M; Naredi P; Wang W; Sund M
Cancer Biomark; 2015; 15(1):1-10. PubMed ID: 25524936
[TBL] [Abstract][Full Text] [Related]
15. Specific expression of endoglin (CD105) in endothelial cells of intratumoral blood and lymphatic vessels in pancreatic cancer.
Yoshitomi H; Kobayashi S; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Miyazaki M
Pancreas; 2008 Oct; 37(3):275-81. PubMed ID: 18815549
[TBL] [Abstract][Full Text] [Related]
16. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
17. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
[TBL] [Abstract][Full Text] [Related]
19. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
20. Role of pancreatic stellate cells and periostin in pancreatic cancer progression.
Liu Y; Du L
Tumour Biol; 2015 May; 36(5):3171-7. PubMed ID: 25840689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
